| A nucleoside-modified mRNA vaccine has been developed by BioNTech and Pfizer for the prevention of COVID-19 |
| Received its first emergency use authorization on 2 December 2020 in the United Kingdom |
| Received its first conditional approval on 19 December 2020 in Switzerland |
| Approved for active immunization to prevent COVID-19 caused by the SARS-CoV-2 virus in people aged 16 and over |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.